Your browser doesn't support javascript.
loading
Combined targeting of the p53 and pRb pathway in neuroblastoma does not lead to synergistic responses.
Schubert, Nil A; Schild, Linda; van Oirschot, Stijn; Keller, Kaylee M; Alles, Lindy K; Vernooij, Lindy; Nulle, Marloes E; Dolman, M Emmy M; van den Boogaard, Marlinde L; Molenaar, Jan J.
Afiliação
  • Schubert NA; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Schild L; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • van Oirschot S; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Keller KM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Alles LK; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Vernooij L; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Nulle ME; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Dolman MEM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • van den Boogaard ML; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Molenaar JJ; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. Electronic address: j.j.molenaar@prinsesmaximacentrum.nl.
Eur J Cancer ; 142: 1-9, 2021 01.
Article em En | MEDLINE | ID: mdl-33190064

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteína Supressora de Tumor p53 / Medicina de Precisão / Neuroblastoma Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteína Supressora de Tumor p53 / Medicina de Precisão / Neuroblastoma Idioma: En Ano de publicação: 2021 Tipo de documento: Article